Merck & Co., Inc.MRKNYSE
LOADING
|||
R&D Expense Growth Under Pressure
Trending lower, below historical average, strong compound growth.
Left:
||||
Year-over-year research & development expense growth
Latest
-41.25%
↓ 350% below average
Average (9y)
16.51%
Historical baseline
Range
High:125.35%
Low:-41.25%
CAGR
+22.5%
Consistent expansion
| Period | Value |
|---|---|
| 2024 | -41.25% |
| 2023 | 125.35% |
| 2022 | 10.64% |
| 2021 | -8.60% |
| 2020 | 37.77% |
| 2019 | -0.29% |
| 2018 | -5.68% |
| 2017 | 0.76% |
| 2016 | 53.06% |
| 2015 | -6.63% |